Health X Platform Limited disclosed that promoter Banwari Lal Mittal acquired an additional 11,671 equity shares worth Rs. 32.76 lakh through market purchase between March 12-13, 2026. This latest acquisition increased his shareholding from 33.8155% to 33.8522%, representing a 0.0367% increase in his stake in the company.

Health X Platform Limited Promoter Banwari Lal Mittal Acquires Additional 11,671 Shares Worth Rs. 32.76 Lakh

Health X Platform Limited has informed stock exchanges about another acquisition of additional equity shares by its promoter Mr. Banwari Lal Mittal. The company disclosed this latest transaction under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 on March 16, 2026.

Latest Share Acquisition Details

Mr. Banwari Lal Mittal, a promoter of Health X Platform Limited, acquired 11,671 equity shares through market purchase in his most recent transaction. The updated transaction details are presented below:

Parameter: Details Number of Shares Acquired: 11,671 equity shares Transaction Value: Rs. 32,75,926.29 (inclusive of taxes) Transaction Period: March 12, 2026 to March 13, 2026 Mode of Acquisition: Market Purchase Date of Intimation: March 14, 2026

Updated Shareholding Pattern

The latest acquisition resulted in a further increase in Mr. Mittal's shareholding in the company. His current shareholding position reflects the cumulative effect of recent transactions:

Shareholding Status: Number of Shares Percentage of Capital Prior to Latest Acquisition: 1,07,56,889 33.8155% Post Latest Acquisition: 1,07,68,560 33.8522% Net Increase: 11,671 0.0367%

Regulatory Compliance

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, submitted the latest disclosure to both BSE Limited and National Stock Exchange of India Limited. The company trades under stock code 533259 on BSE and symbol SASTASUNDR on NSE.

The disclosure was made in Form C as specified under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Compliance Officer Pratap Singh digitally signed the disclosure documents on March 16, 2026, on behalf of the company.

Company Information

Health X Platform Limited operates with CIN L65993WB1989PLC047002 and maintains its registered office at Azimganj House, 2nd Floor, 7, Abanindra Nath Thakur Sarani, Kolkata. The company's ISIN is INE019J01013, and it continues to operate under its healthcare and platform business model following its name change from Sastasundar Ventures Limited.

Health X Platform Limited (formerly Sastasundar Ventures Limited) has received board approval for executing a tripartite agreement with its material subsidiary Sastasundar Healthbuddy Limited (SHBL) and Envision India Fund. The board of directors approved the agreement execution under Regulation 30A of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Agreement Framework and Parties

The tripartite agreement involves Health X Platform Limited, SHBL, and Envision India Fund, a qualified institutional buyer registered in Mauritius with registration number GB20025232. The agreement follows the share purchase agreement dated February 25, 2026, where Envision acquired Mitsubishi Corporation's entire shareholding in SHBL comprising 10.14 lakh equity shares valued at Rs. 50.00 crore at Rs. 493.21 per share.

Parameter: Details Agreement Type: Tripartite Agreement Parties: Health X Platform, SHBL, Envision India Fund Envision Registration: GB20025232 (Mauritius) Regulatory Framework: SEBI Regulation 30A Share Purchase Value: Rs. 50.00 crore

Merger and Share Swap Provisions

The tripartite agreement contemplates a scheme of arrangement between Health X Platform and SHBL, whereby SHBL shall be merged with Health X Platform subject to compliance with applicable laws. The merger structure ensures Envision's economic interest in Health X Platform post-merger remains equivalent to its pre-merger stake in SHBL.

If the scheme of arrangement resulting in merger cannot be consummated, Health X Platform will undertake a share swap arrangement to provide Envision equivalent shares in lieu of SHBL holdings. The company previously disclosed in-principle approval for the merger scheme on February 26, 2026.

Post-Transaction Shareholding Structure

Following the completion of the transaction, SHBL's shareholding structure comprises Health X Platform Limited holding 17,100,160 equity shares, Rohto Pharmaceuticals Co., Ltd. with 3,562,064 equity shares, and Envision India Fund with 10,13,766 equity shares, totaling 21,675,990 equity shares.

Shareholder: Equity Shares Health X Platform Limited: 17,100,160 Rohto Pharmaceuticals Co., Ltd.: 3,562,064 Envision India Fund: 10,13,766 Total: 21,675,990

Governance Rights and Board Representation

The tripartite agreement grants Envision India Fund the right to nominate one director on Health X Platform's board in case of material breach or non-consummation of the merger. This provision ensures Envision maintains governance participation aligned with its investment stake and strategic interests in the healthcare platform.

Regulatory Compliance and Disclosure

Company Secretary and Compliance Officer Pratap Singh executed the regulatory disclosure under SEBI guidelines, maintaining transparency with stock exchanges. The transaction falls within related party transaction scope as SHBL is a material subsidiary of Health X Platform, with the company being SHBL's promoter.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.